SILO - Silo Pharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.6 0.01 (1.67%) --- --- 0.0 (-0.33%) 0.01 (1.67%) --- -0.02 (-3.98%) -0.01 (-2.38%)

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-0.23
Diluted EPS:
-0.23
Basic P/E:
-2.6522
Diluted P/E:
-2.6522
RSI(14) 1m:
0.0
VWAP:
0.61
RVol:
0.0026

Events

Period Kind Movement Occurred At
1m Price decrease 1m 0.6 -0.01 (-1.28%) Oct 15 05:40
60m Price decrease 60m 0.6 -0.03 (-5.12%) Oct 14 19:59

Related News